MEDIX HEARTBURN & ACID INDIGESTION ranitidine hydrochloride 167.5 mg tablets blister pack

Country: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

ranitidine hydrochloride, Quantity: 167.5 mg

Disponibbli minn:

Nova Pharmaceuticals Australasia Pty Ltd

INN (Isem Internazzjonali):

Ranitidine hydrochloride

Għamla farmaċewtika:

Tablet, film coated

Kompożizzjoni:

Excipient Ingredients: hypromellose; Castor Oil; croscarmellose sodium; iron oxide yellow; colloidal anhydrous silica; purified talc; microcrystalline cellulose; magnesium stearate; titanium dioxide

Rotta amministrattiva:

Oral

Unitajiet fil-pakkett:

14

Tip ta 'preskrizzjoni:

Not scheduled. Not considered by committee

Indikazzjonijiet terapewtiċi:

Provides effective long-lasting 12-hour relief from heartburn and acid indigestion due to gastro-oesophageal reflux.

Sommarju tal-prodott:

Visual Identification: Creamish to yellowish coloured, convex, film-coated tablet, impressed with the identifying letters ?R? and ?I? on either side of a central division line on one face.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

L-istatus ta 'awtorizzazzjoni:

Licence status A

Data ta 'l-awtorizzazzjoni:

2013-05-23